middle.news
Cynata Therapeutics Resumes Trading After Key Trial Results Released
9:22am on Friday 19th of June, 2026 AEST
•
Healthcare
Read Story
Cynata Therapeutics Resumes Trading After Key Trial Results Released
9:22am on Friday 19th of June, 2026 AEST
Key Points
Trading suspension lifted post clinical trial announcements
Results from Phase 3 Osteoarthritis and Phase 2 GvHD trials released
Market awaits detailed data for clinical and financial implications
Suspension tied to regulatory compliance around material disclosures
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Cynata Therapeutics (ASX:CYP)
OPEN ARTICLE